(MedPage Today) — The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.
Primary support for the preferential…
Source link : https://www.medpagetoday.com/pulmonology/generalpulmonary/117841
Author :
Publish date : 2025-10-07 20:52:00
Copyright for syndicated content belongs to the linked Source.
